Brazil has temporarily suspended its dengue vaccination campaign as a precautionary measure after two deaths and several cases of serious adverse reactions were reported. Further data is needed to establish a link to the vaccine.

<p> <img alt="The vaccine was approved by the regulatory agency ANVISA in late 2025 for people aged 12 to 59, and the campaign began in February with health personnel" height="80" src="https://en.mercopress.com/data/cache/noticias/110414/100x80/vacuna-1160x700.jpg" style="float: left; margin: 0 12px 6px 0; border: 1px solid #333;" width="100" /> Brazil temporarily suspended the dengue vaccination campaign it began in January, after detecting two deaths and several cases of s...